# Allergic Disease Onset Prevention Study

> **NCT05003804** · PHASE1,PHASE2 · COMPLETED · sponsor: **Siolta Therapeutics, Inc.** · enrollment: 283 (actual)

## Conditions studied

- Atopic Dermatitis
- Type 1 Hypersensitivity

## Interventions

- **BIOLOGICAL:** STMC-103H
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05003804
- **Lead sponsor:** Siolta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2024-11-26
- **Final completion:** 2025-10-21
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05003804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05003804, "Allergic Disease Onset Prevention Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05003804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*